Mohamed Awad
Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Artificial Limbs | 12 | 2026 | 215 | 2.810 |
Why?
| | Arthroplasty, Replacement, Hip | 6 | 2024 | 193 | 2.040 |
Why?
| | Osseointegration | 5 | 2025 | 60 | 1.200 |
Why?
| | Surgical Wound Infection | 5 | 2025 | 349 | 1.160 |
Why?
| | Lower Extremity | 4 | 2026 | 453 | 1.130 |
Why?
| | Fractures, Open | 2 | 2025 | 30 | 0.980 |
Why?
| | Arthroplasty, Replacement, Knee | 4 | 2024 | 385 | 0.770 |
Why?
| | Antibiotic Prophylaxis | 1 | 2024 | 140 | 0.760 |
Why?
| | Spine | 1 | 2024 | 184 | 0.740 |
Why?
| | Osteonecrosis | 2 | 2020 | 23 | 0.730 |
Why?
| | Bisphosphonate-Associated Osteonecrosis of the Jaw | 2 | 2019 | 6 | 0.730 |
Why?
| | Bone Density Conservation Agents | 2 | 2020 | 83 | 0.700 |
Why?
| | Arthroplasty, Replacement | 2 | 2019 | 47 | 0.700 |
Why?
| | Orthopedic Procedures | 3 | 2024 | 260 | 0.690 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 59 | 0.610 |
Why?
| | Communicable Disease Control | 1 | 2020 | 88 | 0.600 |
Why?
| | Analgesics, Opioid | 4 | 2026 | 1221 | 0.590 |
Why?
| | Anti-Bacterial Agents | 4 | 2025 | 1942 | 0.590 |
Why?
| | Mandibular Reconstruction | 1 | 2019 | 4 | 0.580 |
Why?
| | Pharmacogenomic Variants | 1 | 2019 | 35 | 0.580 |
Why?
| | Cytochrome P450 Family 3 | 1 | 2018 | 3 | 0.570 |
Why?
| | Drug Interactions | 2 | 2022 | 405 | 0.570 |
Why?
| | Fibula | 1 | 2019 | 37 | 0.560 |
Why?
| | Pharmacogenomic Testing | 1 | 2019 | 63 | 0.560 |
Why?
| | Operating Rooms | 1 | 2020 | 145 | 0.550 |
Why?
| | Free Tissue Flaps | 1 | 2019 | 53 | 0.540 |
Why?
| | DNA, Plant | 1 | 2017 | 17 | 0.520 |
Why?
| | Quality of Life | 3 | 2026 | 3200 | 0.520 |
Why?
| | Genome, Chloroplast | 1 | 2017 | 6 | 0.520 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2017 | 16 | 0.520 |
Why?
| | Triticum | 1 | 2017 | 18 | 0.520 |
Why?
| | Pharmacogenetics | 1 | 2018 | 176 | 0.500 |
Why?
| | Femur | 5 | 2025 | 264 | 0.490 |
Why?
| | Hip Joint | 4 | 2025 | 187 | 0.460 |
Why?
| | Orthopedics | 3 | 2024 | 182 | 0.460 |
Why?
| | Pandemics | 2 | 2022 | 1707 | 0.440 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 387 | 0.430 |
Why?
| | Walking | 6 | 2025 | 546 | 0.430 |
Why?
| | Coronavirus Infections | 1 | 2020 | 379 | 0.430 |
Why?
| | Length of Stay | 4 | 2026 | 1358 | 0.420 |
Why?
| | Gait | 4 | 2025 | 322 | 0.420 |
Why?
| | Vancomycin | 2 | 2025 | 96 | 0.390 |
Why?
| | Humans | 45 | 2026 | 146342 | 0.340 |
Why?
| | Cardiology | 3 | 2018 | 363 | 0.310 |
Why?
| | Osteoclasts | 3 | 2020 | 56 | 0.310 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 516 | 0.300 |
Why?
| | Amputees | 3 | 2025 | 101 | 0.300 |
Why?
| | Bone Marrow | 2 | 2023 | 310 | 0.290 |
Why?
| | Diphosphonates | 2 | 2019 | 68 | 0.270 |
Why?
| | Biomechanical Phenomena | 6 | 2025 | 874 | 0.240 |
Why?
| | Laparoscopy | 2 | 2022 | 487 | 0.240 |
Why?
| | Phantom Limb | 1 | 2026 | 8 | 0.230 |
Why?
| | Prosthesis Design | 2 | 2025 | 358 | 0.230 |
Why?
| | Amputation Stumps | 1 | 2026 | 14 | 0.230 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3416 | 0.230 |
Why?
| | Tibial Fractures | 1 | 2026 | 77 | 0.220 |
Why?
| | Tobramycin | 1 | 2025 | 63 | 0.210 |
Why?
| | Hypertension | 3 | 2018 | 1272 | 0.210 |
Why?
| | Spectrin | 1 | 2024 | 13 | 0.210 |
Why?
| | Bone Cements | 1 | 2024 | 39 | 0.210 |
Why?
| | Surgical Drapes | 1 | 2024 | 2 | 0.200 |
Why?
| | Joints | 1 | 2025 | 107 | 0.200 |
Why?
| | Microfilament Proteins | 1 | 2024 | 136 | 0.200 |
Why?
| | Adult | 13 | 2026 | 41087 | 0.200 |
Why?
| | Osteogenesis | 2 | 2023 | 205 | 0.200 |
Why?
| | Orthopedic Surgeons | 1 | 2024 | 30 | 0.190 |
Why?
| | Functional Laterality | 1 | 2024 | 242 | 0.190 |
Why?
| | Mechanotransduction, Cellular | 1 | 2024 | 121 | 0.190 |
Why?
| | Pain | 2 | 2026 | 790 | 0.190 |
Why?
| | Extracellular Traps | 1 | 2023 | 54 | 0.190 |
Why?
| | Fracture Fixation | 1 | 2023 | 82 | 0.180 |
Why?
| | Tibia | 1 | 2024 | 177 | 0.180 |
Why?
| | Testicular Hydrocele | 1 | 2022 | 3 | 0.180 |
Why?
| | Marijuana Use | 1 | 2026 | 218 | 0.180 |
Why?
| | Male | 19 | 2026 | 73396 | 0.180 |
Why?
| | Collateral Ligaments | 1 | 2021 | 17 | 0.170 |
Why?
| | Receptors, Angiotensin | 1 | 2021 | 11 | 0.170 |
Why?
| | Pressure Ulcer | 1 | 2022 | 41 | 0.170 |
Why?
| | Tooth Extraction | 2 | 2020 | 30 | 0.170 |
Why?
| | Meniscus | 1 | 2021 | 23 | 0.170 |
Why?
| | Hernia, Inguinal | 1 | 2022 | 47 | 0.170 |
Why?
| | Stroke | 2 | 2021 | 1287 | 0.170 |
Why?
| | Probability | 1 | 2022 | 309 | 0.170 |
Why?
| | Social Media | 1 | 2024 | 159 | 0.160 |
Why?
| | Trigger Finger Disorder | 1 | 2020 | 8 | 0.160 |
Why?
| | Tissue Preservation | 1 | 2020 | 11 | 0.160 |
Why?
| | Operative Time | 1 | 2021 | 195 | 0.160 |
Why?
| | Knee Injuries | 1 | 2021 | 121 | 0.160 |
Why?
| | Blood Loss, Surgical | 1 | 2021 | 117 | 0.160 |
Why?
| | Respiratory Protective Devices | 1 | 2020 | 15 | 0.160 |
Why?
| | Carrier Proteins | 1 | 2024 | 728 | 0.160 |
Why?
| | Patient Readmission | 2 | 2026 | 778 | 0.160 |
Why?
| | Jaw Diseases | 1 | 2020 | 5 | 0.150 |
Why?
| | Bone and Bones | 2 | 2020 | 319 | 0.150 |
Why?
| | Polymorphism, Genetic | 1 | 2022 | 612 | 0.150 |
Why?
| | Cell Differentiation | 4 | 2023 | 1982 | 0.150 |
Why?
| | Urinary Tract Infections | 1 | 2022 | 209 | 0.150 |
Why?
| | Middle Aged | 10 | 2026 | 36619 | 0.150 |
Why?
| | Female | 15 | 2026 | 79499 | 0.150 |
Why?
| | Aged | 8 | 2026 | 26432 | 0.140 |
Why?
| | Teratoma | 1 | 2020 | 121 | 0.140 |
Why?
| | Peptide Hormones | 1 | 2019 | 11 | 0.140 |
Why?
| | Osteoarthritis, Knee | 1 | 2023 | 291 | 0.140 |
Why?
| | Dipeptidyl Peptidase 4 | 1 | 2019 | 15 | 0.140 |
Why?
| | Surgeons | 1 | 2024 | 351 | 0.140 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2019 | 199 | 0.140 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2021 | 218 | 0.140 |
Why?
| | Time Factors | 3 | 2025 | 7109 | 0.140 |
Why?
| | Ovary | 1 | 2020 | 236 | 0.140 |
Why?
| | Collagen Type I | 1 | 2019 | 144 | 0.140 |
Why?
| | Bone Resorption | 1 | 2019 | 81 | 0.140 |
Why?
| | Cerebrovascular Circulation | 2 | 2019 | 293 | 0.140 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 133 | 0.140 |
Why?
| | Bone Transplantation | 1 | 2019 | 91 | 0.140 |
Why?
| | Jaw | 1 | 2018 | 27 | 0.130 |
Why?
| | Malnutrition | 1 | 2019 | 87 | 0.130 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2018 | 33 | 0.130 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 332 | 0.130 |
Why?
| | Inservice Training | 1 | 2018 | 115 | 0.130 |
Why?
| | Perioperative Care | 1 | 2020 | 235 | 0.130 |
Why?
| | Dementia, Vascular | 1 | 2017 | 18 | 0.130 |
Why?
| | Physical Conditioning, Animal | 1 | 2019 | 243 | 0.130 |
Why?
| | Education, Medical, Continuing | 1 | 2018 | 130 | 0.130 |
Why?
| | Certification | 1 | 2018 | 118 | 0.130 |
Why?
| | Occupational Health | 1 | 2020 | 212 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 288 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1763 | 0.120 |
Why?
| | Ischemic Preconditioning | 1 | 2017 | 47 | 0.120 |
Why?
| | Retrospective Studies | 6 | 2026 | 17438 | 0.120 |
Why?
| | Recovery of Function | 1 | 2021 | 725 | 0.120 |
Why?
| | Nutritional Status | 1 | 2019 | 346 | 0.120 |
Why?
| | Cytokines | 3 | 2019 | 2081 | 0.120 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 372 | 0.120 |
Why?
| | Patient Safety | 1 | 2020 | 352 | 0.120 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1591 | 0.120 |
Why?
| | Preoperative Care | 1 | 2019 | 396 | 0.120 |
Why?
| | Dendritic Cells | 1 | 2020 | 509 | 0.120 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 176 | 0.120 |
Why?
| | Program Evaluation | 1 | 2020 | 952 | 0.110 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 712 | 0.110 |
Why?
| | Homeostasis | 1 | 2020 | 646 | 0.110 |
Why?
| | Primary Prevention | 1 | 2017 | 222 | 0.110 |
Why?
| | Vascular Remodeling | 1 | 2017 | 208 | 0.110 |
Why?
| | Consensus | 1 | 2017 | 467 | 0.110 |
Why?
| | Pain Management | 1 | 2018 | 421 | 0.100 |
Why?
| | Postoperative Complications | 3 | 2022 | 3034 | 0.100 |
Why?
| | Antihypertensive Agents | 1 | 2018 | 519 | 0.100 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 604 | 0.100 |
Why?
| | Pediatrics | 1 | 2022 | 1124 | 0.100 |
Why?
| | Peptides | 1 | 2019 | 992 | 0.100 |
Why?
| | Arthroplasty | 2 | 2024 | 60 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2023 | 1818 | 0.100 |
Why?
| | Societies, Medical | 1 | 2017 | 907 | 0.090 |
Why?
| | Disease Management | 1 | 2017 | 651 | 0.090 |
Why?
| | Emergency Medical Services | 1 | 2020 | 680 | 0.090 |
Why?
| | Pain Measurement | 2 | 2026 | 573 | 0.090 |
Why?
| | Computational Biology | 1 | 2017 | 678 | 0.090 |
Why?
| | Brain Injuries, Traumatic | 1 | 2019 | 466 | 0.090 |
Why?
| | Animals | 11 | 2024 | 38106 | 0.090 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 1101 | 0.090 |
Why?
| | Prosthesis Implantation | 2 | 2023 | 156 | 0.090 |
Why?
| | Blood Pressure | 1 | 2018 | 1765 | 0.090 |
Why?
| | Mice | 7 | 2024 | 18297 | 0.080 |
Why?
| | Cognitive Dysfunction | 1 | 2017 | 481 | 0.080 |
Why?
| | Biomarkers | 2 | 2019 | 4340 | 0.080 |
Why?
| | Knee Joint | 2 | 2025 | 453 | 0.080 |
Why?
| | Body Mass Index | 1 | 2019 | 2458 | 0.080 |
Why?
| | Imidazoles | 2 | 2021 | 245 | 0.070 |
Why?
| | X-Ray Microtomography | 2 | 2019 | 117 | 0.070 |
Why?
| | Africa South of the Sahara | 2 | 2017 | 56 | 0.060 |
Why?
| | Brain | 1 | 2019 | 2991 | 0.060 |
Why?
| | Wound Healing | 2 | 2020 | 354 | 0.060 |
Why?
| | Rats | 3 | 2021 | 5586 | 0.060 |
Why?
| | United States | 2 | 2022 | 16136 | 0.060 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 2026 | 61 | 0.060 |
Why?
| | Inflammation | 3 | 2023 | 2919 | 0.050 |
Why?
| | Powders | 1 | 2025 | 45 | 0.050 |
Why?
| | Administration, Topical | 1 | 2025 | 154 | 0.050 |
Why?
| | Morphine | 1 | 2026 | 171 | 0.050 |
Why?
| | Osteocytes | 1 | 2024 | 24 | 0.050 |
Why?
| | Iodophors | 1 | 2024 | 3 | 0.050 |
Why?
| | Mental Recall | 1 | 2026 | 226 | 0.050 |
Why?
| | Canada | 1 | 2025 | 432 | 0.050 |
Why?
| | Prosthesis-Related Infections | 1 | 2024 | 100 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 350 | 0.050 |
Why?
| | Deoxyribonuclease I | 1 | 2023 | 42 | 0.050 |
Why?
| | Postoperative Period | 1 | 2024 | 355 | 0.050 |
Why?
| | Foot | 1 | 2024 | 109 | 0.050 |
Why?
| | Weight-Bearing | 1 | 2024 | 186 | 0.050 |
Why?
| | Calcium Phosphates | 1 | 2023 | 28 | 0.050 |
Why?
| | Movement | 1 | 2025 | 290 | 0.050 |
Why?
| | Scandinavian and Nordic Countries | 1 | 2022 | 14 | 0.050 |
Why?
| | Adipogenesis | 1 | 2023 | 56 | 0.050 |
Why?
| | Glycosylation | 1 | 2023 | 177 | 0.050 |
Why?
| | Activities of Daily Living | 1 | 2026 | 442 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2024 | 497 | 0.040 |
Why?
| | Inguinal Canal | 1 | 2022 | 10 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2026 | 5899 | 0.040 |
Why?
| | Anti-Infective Agents | 1 | 2024 | 234 | 0.040 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2021 | 8 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2022 | 163 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2023 | 328 | 0.040 |
Why?
| | Range of Motion, Articular | 1 | 2024 | 446 | 0.040 |
Why?
| | Iatrogenic Disease | 1 | 2022 | 74 | 0.040 |
Why?
| | Mammals | 1 | 2023 | 288 | 0.040 |
Why?
| | Menisci, Tibial | 1 | 2021 | 79 | 0.040 |
Why?
| | Anesthesia, General | 1 | 2022 | 124 | 0.040 |
Why?
| | Cell Survival | 1 | 2024 | 1105 | 0.040 |
Why?
| | Postural Balance | 1 | 2024 | 249 | 0.040 |
Why?
| | Thiophenes | 1 | 2021 | 117 | 0.040 |
Why?
| | Cell Membrane | 1 | 2024 | 701 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2023 | 1361 | 0.040 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 185 | 0.040 |
Why?
| | Arthroscopy | 1 | 2021 | 281 | 0.040 |
Why?
| | Health Policy | 1 | 2022 | 399 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2599 | 0.040 |
Why?
| | Nutrition Assessment | 1 | 2019 | 90 | 0.040 |
Why?
| | Equipment Design | 1 | 2020 | 520 | 0.030 |
Why?
| | TGF-beta Superfamily Proteins | 1 | 2018 | 5 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2019 | 451 | 0.030 |
Why?
| | Africa | 1 | 2018 | 119 | 0.030 |
Why?
| | Proteolysis | 1 | 2019 | 174 | 0.030 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2018 | 85 | 0.030 |
Why?
| | Edetic Acid | 1 | 2018 | 47 | 0.030 |
Why?
| | Molar | 1 | 2018 | 47 | 0.030 |
Why?
| | Intervertebral Disc | 1 | 2018 | 35 | 0.030 |
Why?
| | RAW 264.7 Cells | 1 | 2018 | 51 | 0.030 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2018 | 93 | 0.030 |
Why?
| | Myelin Basic Protein | 1 | 2017 | 44 | 0.030 |
Why?
| | Chelating Agents | 1 | 2018 | 75 | 0.030 |
Why?
| | Ultrasonography | 1 | 2021 | 788 | 0.030 |
Why?
| | Sulfonamides | 1 | 2021 | 594 | 0.030 |
Why?
| | Nitrites | 1 | 2017 | 85 | 0.030 |
Why?
| | Neutrophils | 1 | 2023 | 1133 | 0.030 |
Why?
| | Maze Learning | 1 | 2017 | 106 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2024 | 3125 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 11821 | 0.030 |
Why?
| | Rabbits | 1 | 2018 | 651 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 187 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1998 | 0.030 |
Why?
| | Ligands | 1 | 2019 | 678 | 0.030 |
Why?
| | Infant | 2 | 2022 | 10114 | 0.030 |
Why?
| | Angiography | 1 | 2017 | 206 | 0.030 |
Why?
| | Random Allocation | 1 | 2017 | 366 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 426 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2020 | 565 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 738 | 0.030 |
Why?
| | Morbidity | 1 | 2017 | 319 | 0.030 |
Why?
| | Regeneration | 1 | 2018 | 199 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2018 | 320 | 0.030 |
Why?
| | Neovascularization, Pathologic | 1 | 2017 | 287 | 0.030 |
Why?
| | Incidence | 1 | 2022 | 2936 | 0.030 |
Why?
| | Actins | 1 | 2017 | 422 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 674 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2018 | 729 | 0.030 |
Why?
| | Amino Acids | 1 | 2018 | 515 | 0.030 |
Why?
| | Cognition | 1 | 2021 | 1292 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2363 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2020 | 2791 | 0.020 |
Why?
| | Patient Care Team | 1 | 2018 | 701 | 0.020 |
Why?
| | MicroRNAs | 1 | 2019 | 699 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2018 | 2537 | 0.020 |
Why?
| | Calcium | 1 | 2018 | 1181 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 6077 | 0.020 |
Why?
| | Curriculum | 1 | 2018 | 1079 | 0.020 |
Why?
| | Prospective Studies | 1 | 2024 | 8123 | 0.020 |
Why?
| | Child | 2 | 2022 | 22693 | 0.020 |
Why?
| | Prevalence | 1 | 2017 | 2861 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2502 | 0.020 |
Why?
| | Macrophages | 1 | 2017 | 1532 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3926 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10921 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4580 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 6034 | 0.010 |
Why?
| | Signal Transduction | 1 | 2019 | 5246 | 0.010 |
Why?
| | Child, Preschool | 1 | 2020 | 11913 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 22557 | 0.010 |
Why?
|
|
Awad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|